The complexity of developing and manufacturing GMP peptides can often be a significant barrier to scientists. Fortunately, Contract Development and Manufacturing Organizations (CDMOs) have emerged as valuable partners in this industry. With specialized expertise and advanced facilities, CDMOs can expedite the development process, enabling companies